8-K
filed April 4, 2024, 7:59 PM ET
ticker SOLV
CIK 0001964738
other material
confidence high
sentiment neutral
materiality 0.90
Solventum completes 3M spin-off, begins trading on NYSE as SOLV
Solventum Corp
- 80.1% of Solventum shares distributed to 3M stockholders on April 1, 2024; spin-off effective 3:30 a.m. ET.
- Solventum reported $8.2B sales in 2023; employs 22,000 people across four business segments.
- New executive team: CEO Bryan Hanson, CFO Wayde McMillan, board chair Carrie Cox.
- Board reconstituted to 11 members with four committees (Audit, Governance, Talent, Science/Quality).
- Separation agreements signed with 3M covering transition services, tax, IP, supply, and trademarks.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Paul Harrington was appointed as Chief Supply Chain Officer at Solventum Corp.
- Action
- appointed
- Role
- Chief Supply Chain Officer
Exact text from the filing
Paul Harrington Chief Supply Chain Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Marcela Kirberger was appointed as Chief Legal Affairs Officer, Corporate Secretary at Solventum Corp.
- Action
- appointed
- Role
- Chief Legal Affairs Officer, Corporate Secretary
Exact text from the filing
Marcela Kirberger Chief Legal Affairs Officer, Corporate Secretary
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Tammy Gomez was appointed as Chief Human Resources Officer at Solventum Corp.
- Action
- appointed
- Role
- Chief Human Resources Officer
Exact text from the filing
Tammy Gomez Chief Human Resources Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mary Wilcox was appointed as Senior Vice President, Controller and Chief Accounting Officer at Solventum Corp.
- Action
- appointed
- Role
- Senior Vice President, Controller and Chief Accounting Officer
Exact text from the filing
Mary Wilcox Senior Vice President, Controller and Chief Accounting Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Amy Landucci was appointed as Chief Information and Digital Officer at Solventum Corp.
- Action
- appointed
- Role
- Chief Information and Digital Officer
Exact text from the filing
Amy Landucci Chief Information and Digital Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Bryan Hanson was appointed as Chief Executive Officer at Solventum Corp.
- Action
- appointed
- Role
- Chief Executive Officer
Exact text from the filing
Bryan Hanson Chief Executive Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Chris Barry was appointed as Executive Vice President and Group President, Medical Solutions at Solventum Corp.
- Action
- appointed
- Role
- Executive Vice President and Group President, Medical Solutions
Exact text from the filing
Chris Barry Executive Vice President and Group President, Medical Solutions
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Wayde McMillan was appointed as Chief Financial Officer at Solventum Corp.
- Action
- appointed
- Role
- Chief Financial Officer
Exact text from the filing
Wayde McMillan Chief Financial Officer
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Solventum Corp: Adoption of Corporate Governance Guidelines and Board of Directors Code of Business Conduct and Ethics.
- Change
- code of ethics
Exact text from the filing
In connection with the Distribution, the Board adopted Corporate Governance Guidelines and a Board of Directors Code of Business Conduct and Ethics, effective as of the Effective Time.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Solventum Corp: Amended and restated Certificate of Incorporation effective March 31, 2024 (effective 2024-03-31).
- Change
- charter amendment
- Effective
- 2024-03-31
Exact text from the filing
Effective as of 3:30 a.m. Eastern Time on March 31, 2024, Solventum amended and restated its Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”)
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Solventum Corp: Amended and restated Bylaws effective March 31, 2024 (effective 2024-03-31).
- Change
- bylaw amendment
- Effective
- 2024-03-31
Exact text from the filing
immediately thereafter, amended and restated its Bylaws (the “Amended and Restated Bylaws”)
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Solventum Corp entered into Separation and Distribution Agreement and related agreements with 3M Company valued at Entry into multiple separation-related agreements including Separation and Distribution Agreement, T (effective 2024-03-31).
- Action
- entry
- Agreement
- supply
- Counterparty
- 3M Company
- Value
- Entry into multiple separation-related agreements including Separation and Distribution Agreement, T
- Effective
- 2024-03-31
Exact text from the filing
On March 31, 2024, Solventum Corporation (“Solventum”) entered into several agreements with 3M Company (“3M”) in connection with the spin-off of 3M’s health care business (the “Separation”) through the pro rata distribution of 80.1% of the issued and outstanding shares of common stock, par value $0.01 per share, of Solventum to 3M’s stockholders of record as of the close of business on March 18, 2024 (the “Distribution”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.